InvestSMART

Paragon Care Limited (ASX:PGC)

ALERT: Price-sensitive ASX Announcement for PGC
Current share price for PGC : $0.145 -0.06 (-29.27%)+
Announcement
Release
25 Feb 2026 9:02AM
Price at Release
$0.205
Full Release
download
Summary
Paragon Care Limited reported its FY26 half-year financial results, revealing a 2.9% increase in revenue to $1.9 billion. The underlying EBITDA grew by 3.1%, reaching $49 million. However, statutory EBITDA was significantly impacted by non-recurring expenses, resulting in a net loss after tax of $21.3 million. Key contributors to revenue growth included contract logistics and medical technology sectors, with notable organic growth in the Asia region. The company continued its strategic acquisitions to enhance its market presence across ANZ and Asia. Paragon Care is focused on reducing its net debt, which stood at $287.5 million, by leveraging new debt facilities for acquisitions. The outlook for FY26 remains optimistic, with expected revenue between $3.6 to $3.7 billion and underlying EBITDA ranging from $97 to $107 million. No interim dividend was declared as the company focuses on strategic growth and restructuring efforts.
Key Points
  • Revenue increased by 2.9% to $1.9 billion.
  • Underlying EBITDA grew by 3.1% to $49 million.
  • Statutory EBITDA resulted in a net loss after tax of $21.3 million.
  • Contract logistics and medical technology sectors showed strong performance.
  • Significant organic growth observed in the Asia region.
  • Strategic acquisitions continued to enhance market presence.
  • Net debt was $287.5 million, with new debt facilities used for acquisitions.
  • FY26 revenue guidance is between $3.6 to $3.7 billion.
  • No interim dividend declared, focusing on growth and restructuring.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.